http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007118-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5513c4f3ebe2b6ae13b8b87eb430c7ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcce63b212704284382017151a108fc4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2004-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba21b5f5c4b9dd36c9c0b0afd812935
publicationDate 2005-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005007118-A3
titleOfInvention Treatment or prevention of damage due to radiation exposure
abstract A method of treatment or prevention of damage due to ionizing radiation exposure involves administering to a subject in need of such treatment an effective amount of a composition containing 1) a compound including a radiation damage-inhibiting polypeptide containing amino acid sequence LKKTET (such as Thymosin β4), a conservative variant of LKKTET, an actin-sequestering agent, an anti-inflammatory agent; 2) an agent which stimulates production of the compound in the subject; 3) an agent which regulates the compound in the subject; or 4) an antagonist of the compound, so as to inhibit radiation damage in the subject.
priorityDate 2003-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003060405-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03020215-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0006190-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID793949
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81814
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601108
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID781334
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19241
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7114
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132341
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399438

Total number of triples: 30.